Xavier Aparicio
Consultant, EVERSANA MANAGMENT CONSULTING
Expertise:
Xavier is a Consultant at EVERSANA MANAGEMENT CONSULTING with applied and academic life science industry experience. Xavier has worked on a variety of engagements across the Market Access and Launch & Complete Commercialization practices, and he brings focused expertise in the therapeutic areas of neuroscience and gastroenterology.
Xavier holds a Master of Business and Science from Keck Graduate Institute at The Claremont Colleges, a Certificate of Bioscience Industry Law and Practice from Southwestern Law School, and a Bachelor of Science from UC Berkeley.
Articles by Xavier Aparicio
Build the Launch, Then Cut the Deal: A Smarter Playbook for Emerging Biotech Value
For emerging and late-stage biotechs, out-licensing is often viewed as the safer path. Data from our five-year analysis of real-world licensing deal outcomes tells a different story. In this paper, EVERSANA experts break down two critical decisions: Out-license vs. launch independently? If the former, at which stage will out-licensing maximize transactional value? Our experts dive into the key launch and licensing paths that biotechs consider, revealing when commercialization becomes your strongest leverage for long-term value creation. “Data consistently shows that companies launching and […]